A record for the reading desk
Retatrutide
Aliases: LY3437943
The recorded fields, their references, and a question worth keeping.
- Status
- Investigational
- Evidence label
- Randomized evidence
- Index topics
- Metabolism
- Status as of
Record / 01
Recorded fields
- Mechanism
- Activates GIP, GLP-1 and glucagon receptors.
- Evidence
- A randomized obesity trial was funded by Lilly.
- Limitations
- Trial averages do not predict an individual outcome.
- Safety
- The trial reported gastrointestinal adverse events.
- Route context
- Studied as a subcutaneous injection.
- Approval scope
- Investigational; no FDA-approved product.
Reasoning / 02
A note for your reading
A conclusion may depend on choices made while turning records into a summary. Imagine two reasonable ways to handle an ambiguous entry. If they lead to different interpretations, choosing one silently would hide a decision that matters. Ask to see what changes when that choice changes while the other steps stay fixed. If the interpretation remains similar, that supports its stability under this particular choice. If it shifts, the choice belongs in the explanation. Either way, examining an alternative helps show which parts of the reasoning carry the result.
Keep asking / 03
Three questions to carry forward
- Which reasonable processing choice could most influence the interpretation of these records?
- What changes when that choice changes and the other steps stay fixed?
- How should the conclusion acknowledge a decision that materially affects its interpretation?
Trace the record / 04
References
- FDA GLP-1
FDA · Checked
- Jastreboff
PubMed · Checked